Project Grant R01MH135862
Award Date
1/10/25
Completion Date
11/30/28
Dollars Obligated
$385K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38163, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $183,096 to the University of Maryland, Baltimore to study the structural, functional, and neurobehavioral consequences of COVID-19 infection in adolescents. The key objectives are to: 1) Identify morphometric and microstructural brain abnormalities associated with SARS-CoV-2 infection through longitudinal MRI data analysis; 2) Determine if...
The National Institute of Mental Health (NIMH) awarded a Project Grant (CFDA 93.242) in the amount of $797,157 to Yale University to conduct research on understanding circuit dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC) with neuropsychiatric manifestations. The project aims to leverage Yale's expertise in neuroscience and neuroimaging to identify brain circuit-level changes and potential compensatory mechanisms associated with cognitive deficits and mood alterations observed...
This federal Project Grant award from the National Institutes of Health National Institute of Mental Health provides $6,499,884 to Yale University under the Mental Health Research Grants program (CFDA 93.242) to study the longitudinal nervous system consequences of SARS-CoV-2 in people with HIV-1 treated in early infection. The award will fund research from September 2022 to September 2025 to analyze pre- and post-COVID-19 data from a cohort of early antiretroviral therapy-treated people with...
The National Institute of Mental Health (NIMH) awarded a $833,123 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Cedars-Sinai Medical Center in West Hollywood, CA. The grant, titled "SARS-COV-2 AND SOCIAL DETERMINANTS OF HEALTH IMPACT ON INFLAMMATION ASSOCIATED DEPRESSION RISK (SSIDR)," aims to provide a detailed understanding of how upstream eicosanoid pathways can be variably active, imbalanced, and perturbed in relation to an individual's propensity for developing...
This Project Grant award from the National Institutes of Health (CFDA 93.310 - Trans-NIH Research Support) provides $600,000 to Rush University Medical Center in Chicago to investigate the role of antibodies in the neurological effects of COVID-19, known as "neurocovid-19". The central hypothesis is that inflammatory antibodies associated with SARS-CoV-2 infection can trigger activation and damage to brain cells and endothelial cells, disrupting brain homeostasis. The research aims...
This three-year, $6.5 million project grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund research under the Aging Research program (CFDA 93.866). The grantee, the Regents of the University of Minnesota, will assess the acute and long-term impacts of SARS-CoV-2 infection on cognitive function and neuropathology in aging and Alzheimer's disease. Specifically, the University of Minnesota researchers will test hypotheses about how the...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research to understand the mechanisms by which SARS-CoV-2 infection can lead to long-lasting neurological impacts known as post-acute sequelae of COVID-19 (NEUROPASC). The $801,329 grant, with a period of performance from December 1, 2024 to November 30, 2029, will be...
This three-year, $3.456 million project grant from the National Institute of Mental Health (NIMH) Mental Health Research Grants program (CFDA 93.242) will fund research into the role of microglia in neurodevelopmental disorders. The grantee, Cold Spring Harbor Laboratory, will merge two-photon imaging of microglia and synapses in the brains of live mice with single-cell genomics and CRISPR screens. This will help define microglia's role in experience-dependent synaptic refinement, a process...
This $3,659,973 Project Grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of South Florida. The grant supports a multi-year research initiative to investigate the molecular mechanisms underlying the neurological sequelae, known as "Neuro-COVID," observed in some COVID-19 patients. The key objectives are to: Assess how aging exacerbates inflammation and tauopathy (abnormal tau protein buildup) following COVID-19 infection in mouse...
This $1,120,805 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), will support research to investigate how prior SARS-CoV-2 infection may increase the risk of vascular contributions to cognitive impairment and dementia (VCID). The research aims to: Determine how prior SARS-CoV-2 infection influences blood-brain barrier...